Winning the Battle Against Endotoxic Septic Shock - Spectral Medical …
2024年11月12日 · At Spectral Medical Inc, we remain dedicated to fighting endotoxic septic shock with our unique theranostic approach. This approach combines the EAA™ Endotoxin Activity Assay for rapid diagnosis, followed by targeted endotoxin removal with Toraymyxin™ PMX extracorporeal hemoperfusion .
About - Spectral Medical Inc
At Spectral Medical, we are pioneering a transformative theranostic approach that will enable improved outcomes for patients with endotoxic septic shock (ESS). ESS is a life-threatening condition that arises when the body’s response to infection …
Spectral's EAA™, PMX and Reagents Product Line - Spectral Medical …
Spectral’s EAA™ Endotoxin Activity Assay is the only Health Canada licensed, FDA cleared, and CE marked rapid diagnostic for endotoxin activity in human whole blood. PMX (Toraymyxin™ PMX-20R) is a Polymyxin B extracorporeal direct hemoperfusion adsorption column which is highly effective in removing endotoxin in the bloodstream.
Spectral Medical Inc. (EDT.TO) Stock Price, News, Quote & History ...
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets...
Spectral Medical Inc. (EDT.TO) - Yahoo Finance
Find the latest Spectral Medical Inc. (EDT.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Spectral Medical, Inc. (Spectral Medical, Inc.) - 药物管线_专利_临 …
Methods: In this single-center, serial prospective study, 124 predominantly Caucasian adult patients were recruited within 48 h of admission to Stony Brook University Hospital Intensive Care Unit (ICU). Demographics, vital signs, laboratory data, and outcomes were collected.
Spectral Medical Provides Update on Tigris Clinical Trial and …
TORONTO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided a business update focusing on Tigris, the Company’s follow-on study designed to build on knowledge gained from the earlier ...
Spectral Medical - YouTube
At Spectral Medical, we are pioneering a transformative theranostic approach that will enable improved outcomes for patients with endotoxic septic shock (ESS). This life-threatening condition...
Spectral Medical Inc. - LinkedIn
Spectral Medical is a Phase 3 company advancing the fight against endotoxic septic shock through an innovative theranostic approach. This unique strategy combines the EAA™ Endotoxin Activity...
Investor Relations - Sepsis Theranostic - Spectral Medical
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA ...
- 某些结果已被删除